507LBA (PB-507) LBA Posters: VRN101099: a novel oral treatment option for patients with advanced solid tumors including brain metastasis driven by HER2 amplification or HER2-activating mutations even with T-DXd resistance
Titel:
507LBA (PB-507) LBA Posters: VRN101099: a novel oral treatment option for patients with advanced solid tumors including brain metastasis driven by HER2 amplification or HER2-activating mutations even with T-DXd resistance
Auteur:
Jung, H.R. Ko, Y. Yoo, J. Kim, S.H. Kim, H. Seo, K. Kim, Y. Lee, S. Im, H. Shin, D. Kim, H. Kim, J. Cho, H.Y. Je, S. Kim, D. Kim, S.